“GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE”. International journal of medical sciences 6, no. 4 (April 30, 2026): 849–855. Accessed August 7, 2026. https://www.academicpublishers.org/journals/index.php/ijms/article/view/13107.